Form4insider filings, from the source

Insider holders · CIK 0001626971

Corvus Pharmaceuticals, Inc. · CRVS

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
OrbiMed Capital GP V LLCDirector—5,967,5845,967,584Mar 14, 2018 · 1:58 pm EDTForm 4
Peter A. ThompsonDirector—5,967,5845,967,584Jun 25, 2018 · 4:06 pm EDTForm 4
ORBIMED ADVISORS LLCDirector—5,967,5845,967,584Mar 14, 2018 · 1:58 pm EDTForm 4
Samuel D IsalyDirector—5,379,3495,379,349Jun 27, 2016 · 6:47 pm EDTForm 4
Novo Holdings A/S10% Owner4,420,516—4,420,516Mar 13, 2018 · 5:12 pm EDTForm 4
Terry P GouldDirector—3,275,6163,275,616Jun 25, 2018 · 4:05 pm EDTForm 4
ADAMS STREET PARTNERS LLC10% Owner—3,275,6163,275,616Jun 25, 2018 · 4:15 pm EDTForm 4
Richard A Miller M.D.President and CEO—1,128,7951,128,795Dec 31, 2018 · 4:16 pm ESTForm 4
Joseph J BuggyEVP Discovery Research84,876266,310351,186Dec 14, 2018 · 4:06 pm ESTForm 4
Leiv LeaChief Financial Officer—149,206149,206Dec 27, 2018 · 4:08 pm ESTForm 4
William Benton JonesSee Remarks113,773—113,773Dec 14, 2018 · 4:09 pm ESTForm 4
Erik J. VernerV.P., Chemistry Research63,773—63,773Dec 14, 2018 · 4:05 pm ESTForm 4
David Scott MooreDirector21,700—21,700Jun 15, 2026 · 5:12 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.